Published in J Hepatol on June 01, 1998
Transcriptional blood signatures distinguish pulmonary tuberculosis, pulmonary sarcoidosis, pneumonias and lung cancers. PLoS One (2013) 1.86
Subcutaneous sarcoidosis: report of two cases and review of the literature. Clin Rheumatol (2011) 1.29
Sarcoidosis after use of interferon for chronic hepatitis C: report of a case and review of the literature. Dig Dis Sci (2003) 1.06
Development of sarcoidosis following completion of treatment for hepatitis C with pegylated interferon-{alpha}2a and ribavirin: a case report and literature review. Clin Med Res (2010) 1.00
Interferon-β-induced pulmonary sarcoidosis in a 30-year-old woman treated for multiple sclerosis: a case report. J Med Case Rep (2012) 0.96
Hepatic sarcoidosis associated with pegylated interferon alfa therapy for chronic hepatitis C: case report and review of literature. Dig Dis Sci (2008) 0.93
Barriers to hepatitis C antiviral therapy in HIV/HCV co-infected patients in the United States: a review. AIDS Patient Care STDS (2014) 0.92
Systemic sarcoidosis presenting as a granulomatous tattoo reaction secondary to interferon-alpha treatment for chronic hepatitis C and review of the literature. Dig Dis Sci (2002) 0.91
Dendritic cells in the pathogenesis of sarcoidosis. Am J Respir Cell Mol Biol (2009) 0.81
Spontaneous resolution of systemic sarcoidosis in a patient with chronic hepatitis C without interferon therapy. World J Gastroenterol (2006) 0.81
Sarcoidosis-associated hepatitis C virus infection. Dig Dis Sci (2002) 0.81
Improvement of sarcoidosis under therapy with interferon-alpha 2b for chronic hepatitis B virus infection. J Hepatol (1999) 0.80
Hepatic sarcoidosis found as a small liver SOL in a patient with type C cirrhosis. J Gastroenterol (2005) 0.76
Drug-induced Liver Injury: The Hepatic Pathologist's Approach. Gastroenterol Clin North Am (2017) 0.75
Safety, Tolerability, and Immunogenicity of Interferons. Pharmaceuticals (Basel) (2010) 0.75
Cutaneous Sarcoidosis: An Uncommon Side Effect of Pegylated Interferon and Ribavirin Use for Chronic Hepatitis C. Case Rep Gastroenterol (2009) 0.75
Recurrence of hepatitis C virus after loss of virus-specific CD4(+) T-cell response in acute hepatitis C. Gastroenterology (1999) 5.79
Possible mechanism involving T-lymphocyte response to non-structural protein 3 in viral clearance in acute hepatitis C virus infection. Lancet (1995) 4.71
Sustained dysfunction of antiviral CD8+ T lymphocytes after infection with hepatitis C virus. J Virol (2001) 4.48
CD8+ T lymphocyte responses are induced during acute hepatitis C virus infection but are not sustained. Eur J Immunol (2000) 3.36
Association of hepatitis C virus-specific CD8+ T cells with viral clearance in acute hepatitis C. J Infect Dis (2000) 2.98
Seasonal fluctuations of gadolinium-enhancing magnetic resonance imaging lesions in multiple sclerosis. Ann Neurol (2000) 2.73
[21-year-old patient with recurrent diarrhea, weight loss, leg edema and iron deficiency. Gluten sensitive sprue]. Internist (Berl) (2002) 2.04
Immunodominant CD4+ T-cell epitope within nonstructural protein 3 in acute hepatitis C virus infection. J Virol (1997) 1.98
Hepatitis B virus antigen-specific T-cell activation in patients with acute and chronic hepatitis B. J Hepatol (1991) 1.76
Mapping of immunodominant CD4+ T lymphocyte epitopes of hepatitis C virus antigens and their relevance during the course of chronic infection. Hepatology (1995) 1.72
Activation of a heterogeneous hepatitis B (HB) core and e antigen-specific CD4+ T-cell population during seroconversion to anti-HBe and anti-HBs in hepatitis B virus infection. J Virol (1995) 1.71
Differential antigen-processing pathways of the hepatitis B virus e and core proteins. Gastroenterology (1999) 1.52
Quantification of hepatitis B virus DNA over a wide range from serum for studying viral replicative activity in response to treatment and in recurrent infection. Hepatology (1995) 1.50
Immunoglobulin M antibodies to hepatitis B core antigen: evaluation of enzyme immunoassay for diagnosis of hepatitis B virus infection. J Clin Microbiol (1981) 1.48
Antibodies to hepatitis C virus. Lancet (1989) 1.47
Identification of HLA-A3 and -B7-restricted CTL response to hepatitis C virus in patients with acute and chronic hepatitis C. J Immunol (1999) 1.46
Hepatitis B vaccination: how long does protection last? Lancet (1984) 1.43
Treatment of benign ureterointestinal anastomotic strictures with permanent ureteral Wallstent after Camey and Wallace urinary diversion: long-term follow-up. J Endourol (2001) 1.39
Precore mutant hepatitis B virus infection and liver disease. Gastroenterology (1992) 1.31
Purification, fractionation and assay of antibody-dependent lymphocytic effector cells (K cells) in human blood. Scand J Immunol (1976) 1.27
Involvement of the cytotoxic/suppressor T-cell subset in liver tissue injury of patients with acute and chronic liver diseases. Gastroenterology (1983) 1.26
Individuals with antibodies against hepatitis B core antigen as the only serological marker for hepatitis B infection: high percentage of carriers of hepatitis B and C virus. J Hepatol (1995) 1.20
Ursodeoxycholic acid for treatment of primary sclerosing cholangitis: a placebo-controlled trial. Hepatology (1992) 1.19
A vigorous virus-specific CD4+ T cell response may contribute to the association of HLA-DR13 with viral clearance in hepatitis B. Clin Exp Immunol (1998) 1.19
Erdheim-Chester disease: a case report and literature overview. Eur Radiol (1999) 1.16
Malignant mixed epithelial and stromal tumor of the kidney. Virchows Arch (2001) 1.16
Hepatitis B virus genomes that cannot synthesize pre-S2 proteins occur frequently and as dominant virus populations in chronic carriers in Italy. Virology (1992) 1.15
Absence of mutations in the YMDD motif/B region of the hepatitis B virus polymerase in famciclovir therapy failure. J Hepatol (1999) 1.14
The role of hepatitis C virus specific CD4+ T lymphocytes in acute and chronic hepatitis C. J Mol Med (Berl) (1996) 1.14
Hepatitis after chronic abuse of senna. Lancet (1991) 1.13
Differential lesion patterns in CADASIL and sporadic subcortical arteriosclerotic encephalopathy: MR imaging study with statistical parametric group comparison. Radiology (2001) 1.12
Vigorous peripheral blood cytotoxic T cell response during the acute phase of hepatitis C virus infection. Cell Immunol (2000) 1.12
Prevalence and type of pre-C HBV mutants in anti-HBe positive carriers with chronic liver disease in a highly endemic area. Virology (1991) 1.10
Minimal T-cell-stimulatory sequences and spectrum of HLA restriction of immunodominant CD4+ T-cell epitopes within hepatitis C virus NS3 and NS4 proteins. J Virol (2005) 1.09
Antibodies against hepatitis C virus-like particles and viral clearance in acute and chronic hepatitis C. Hepatology (2000) 1.09
Virus-specific lymphokine production differs quantitatively but not qualitatively in acute and chronic hepatitis B infection. Virology (1999) 1.08
HIV antigen, HIV antibody and serum interferon in a patient with encephalopathy. Infection (1988) 1.05
Liver-derived hepatitis C virus (HCV)-specific CD4(+) T cells recognize multiple HCV epitopes and produce interferon gamma. Hepatology (2000) 1.05
Comparing acoustic radiation force impulse imaging to transient elastography to assess liver stiffness in healthy volunteers with and without valsalva manoeuvre. Clin Hemorheol Microcirc (2010) 1.03
Transient immunological control during acute hepatitis C virus infection: ex vivo analysis of helper T-cell responses. J Viral Hepat (2006) 1.00
Natural cytotoxicity of human Fc gamma-receptor-positive T lymphocytes after surface modulation with immune complexes. Scand J Immunol (1979) 1.00
Improved analysis of 1H-MR spectra in the presence of mobile lipids. Magn Reson Med (2001) 0.99
A role for chronic hepatitis C virus infection in a patient with cutaneous vasculitis, cryoglobulinemia, and chronic liver disease. Effective therapy with interferon-alpha. Dig Dis Sci (1995) 0.98
Characterization of cytolytic effector cells in peripheral blood of healthy individuals and cancer patients. II. Cytotoxicity to allogeneic or autochthonous tumor cells in tissue culture. J Immunol (1977) 0.97
[Pathological anatomy of Waterhouse-Friderichsen syndrome with special reference to disseminated intravascular coagulation]. Dtsch Med Wochenschr (1973) 0.95
Simultaneous occurrence of immunoglobulin-dependent and immunoglobulin-independent mechanisms in natural cytotoxicity of human lymphocytes. J Immunol (1979) 0.94
Anergic TH1 clones specific for hepatitis B virus (HBV) core peptides are inhibitory to other HBV core-specific CD4+ T cells in vitro. J Virol (1996) 0.94
Comparison of hepatitis B core antigens derived from human liver or synthesized in Escherichia coli and evaluation of their use in diagnostic assays for anti-HBc IgM. J Virol Methods (1983) 0.94
Differential expression of MHC class II subregion products on bile duct epithelial cells and hepatocytes in patients with primary biliary cirrhosis. Hepatology (1988) 0.93
Mapping of B-cell epitopes of the human hepatitis B virus X protein. J Virol (1990) 0.93
Chronic diarrhea as a result of intestinal microsposidiosis in a liver transplant recipient. Transplantation (2001) 0.91
[Arterial hypertension and blood pressure profile in patients with Williams-Beuren syndrome]. Z Kardiol (1997) 0.91
Characterization of nucleotide sequences from European hepatitis C virus isolates. Gene (1991) 0.91
Low lipoprotein (a) levels during acute viral hepatitis. Hepatology (1996) 0.89
Serology and interferon production during the early phase of acute hepatitis A. J Infect Dis (1990) 0.88
Immunogenicity of human hepatitis B virus P-gene derived proteins. J Immunol (1989) 0.88
Serum levels and in situ expression of TNF-alpha and TNF-alpha binding proteins in inflammatory liver diseases. Cytokine (1996) 0.88
Blood pressure changes induced by arterial blood withdrawal influence bold signal in anesthesized rats at 7 Tesla: implications for pharmacologic mri. Neuroimage (2001) 0.87
A scientific relational database combined with a report generator for endoscopy in networks: EndoNet. Endoscopy (1998) 0.87
Conserved core protein sequences in hepatitis B virus infected patients without anti-HBc. J Hepatol (1991) 0.86
Strong transient expression of the type I interferon-induced MxA protein in hepatitis A but not in acute hepatitis B and C. Hepatology (1994) 0.86
Frequency dependence and gender effects in visual cortical regions involved in temporal frequency dependent pattern processing. Hum Brain Mapp (2001) 0.86
Hepatitis A infection in chronic carriers of hepatitis B virus. Hepatology (1983) 0.86
Amanita phalloides intoxications in a family of russian immigrants. Case reports and review of the literature with a focus on orthotopic liver transplantation. Z Gastroenterol (1994) 0.85
T lymphocytes from patients with primary biliary cirrhosis produce reduced amounts of lymphotoxin, tumor necrosis factor and interferon-gamma upon mitogen stimulation. J Hepatol (1992) 0.85
Implantation of Accuflex and Strecker stents in malignant bronchial stenoses by flexible bronchoscopy. Chest (1997) 0.85